XTL Biopharmaceuticals Ltd. ADR | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.17 |
Market Cap |
$9.72 M |
Shares Outstanding |
5.14 M |
Public Float |
- |
Address |
5 Badner Sreet Ramat Gan HM 4365603 Israel |
Employees | - |
Website | http://www.xtlbio.com |
Updated | 07/08/2019 |
XTL Biopharmaceuticals Ltd is a biopharmaceutical company, which engages in the acquisition and development of pharmaceutical drugs. Its drug development program focuses on the treatment of systemic lupus erythematosus. The company was founded on March 9, 1993 and is headquartered in Raanana, Israel. |